A pilot study to examine the effect of adjunctive anti-IgE antibody on improving the efficacy and safety of oral immunotherapy for cow's milk allergy.
Not Applicable
- Conditions
- Cow's milk allergy
- Registration Number
- JPRN-UMIN000018794
- Lead Sponsor
- Fujita Health university Faculty of medicine, Department of pediatrics.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with past history of tracheal tubing or ICU admission due to anaphylaxis to foods. 2)Patients with severe systemic disease (Heart diseases, Inflammatory diseases, uncontrolled baronchial asthma). 3)Patients using beta blocker. 4)Patients with past history of hypersensitivity to omalizumab. 5)Patients who do not agree to participate in this study. 6)Patients whom physician regards inadequate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To perform oral immunotherapy (OIT) for cow's milk allergy diagnosed by oral challenge test in combination with anti-IgE therapy and to compare frequency and severity of adverse events until reaching the target amount with conventional OIT.
- Secondary Outcome Measures
Name Time Method